Absence seizures: a review of recent reports with new concepts

John R Hughes1

  • 1Department of Neurology, University of Illinois Medical Center (M/C 796), 912 South Wood Street, Chicago, IL 60612, USA. jhughes@uic.edu

Insights

Childhood and juvenile absence seizures, characterized by 3Hz spike-wave complexes, involve thalamocortical networks and T-calcium channels. Effective treatments include ethosuximide, valproic acid, and lamotrigine.

Area of Science:

  • Neurology
  • Epileptology
  • Neurophysiology

Background:

  • Absence seizures present with bilateral spike-wave (SW) complexes at 3Hz, divided into childhood (onset ~6 years) and juvenile (onset ~12 years) forms.
  • Seizures typically last 9-12 seconds, can be activated by hyperventilation or photic stimulation, and may be accompanied by cognitive, linguistic, and behavioral issues.
  • Generalized tonic-clonic (GTC) seizures can occur, particularly in the juvenile form.

Purpose of the Study:

  • To explore the underlying mechanisms and neurobiology of absence seizures.
  • To present a unified theory of absence epilepsy, integrating existing centrencephalic and corticoreticular concepts.
  • To discuss genetic factors and treatment strategies for absence epilepsy.

Main Methods:

  • Review of existing literature on absence seizure pathophysiology, genetics, and treatment.
  • Analysis of electroencephalography (EEG) findings, including interictal prefrontal activity and ictal SW complexes.
  • Examination of proposed genetic links, such as the T-calcium channel gene CACNA1H.

Main Results:

  • Absence epileptogenesis may involve GABAergic systems and T-calcium channels, with significant roles for the thalamus (reticular nucleus) and frontal cortex.
  • Evidence suggests selective cortical networks, rather than generalized involvement, may underlie absence seizures.
  • EEG shows interictal prefrontal activity and infraslow activity during ictal SW complexes.

Conclusions:

  • Ethosuximide may be safe for GTC seizures as it targets T-calcium currents; valproic acid and lamotrigine are first-line treatments.
  • Zonisamide and levetiracetam are also effective adjunctive therapies for absence epilepsy.
  • Understanding the thalamocortical network and genetic factors like CACNA1H is crucial for advancing absence seizure management.

Related Concept Videos

Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...